Synergistic anti-tumor effect by combinatorial gene-gun therapy using IL-23 and IL-18 cDNA
- 1 October 2004
- journal article
- other
- Published by Elsevier in Journal of Dermatological Science
- Vol. 36 (1) , 66-68
- https://doi.org/10.1016/j.jdermsci.2004.08.001
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- The IL-12 Family of Heterodimeric Cytokines: New Players in the Regulation of T Cell ResponsesPublished by Elsevier ,2003
- Antitumor and Antimetastatic Activity of IL-23The Journal of Immunology, 2003
- Long-lasting gene expression by particle-mediated intramuscular transfection modified with bupivacaine: combinatorial gene therapy with IL-12 and IL-18 cDNA against rat sarcoma at a distant siteCancer Gene Therapy, 2003
- Interleukin-12 in anti-tumor immunity and immunotherapyCytokine & Growth Factor Reviews, 2002
- Gene gun–mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: Successful treatment of oral melanoma and distant skin lesionCancer Gene Therapy, 2001
- Interleukin-18 Regulates Both Th1 and Th2 ResponsesAnnual Review of Immunology, 2001
- Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12Immunity, 2000
- Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.Journal of Clinical Investigation, 1998
- Gene gun and other non-viral approaches for cancer gene therapyNature Medicine, 1995